https://www.selleckchem.com/pr....oducts/myf-01-37.htm
001). Downstaging by 3 stages was the strongest independent predictor of overall survival (hazard ratio 0.17; 95% confidence interval 0.062-0.44). Overall survival was significantly better among patients in the ypTNM groups when a stage-by-stage comparison was performed with the pTNM group. Pathological stage is a more accurate predictor of prognosis compared clinical stage with downstaged patients benefiting from lower recurrence rates and improved overall survival. Patients downstaged due to neoadjuvant chemotherapy may potentia
Like
Comment
Share
